4
Changes in Ownership
Nurix Therapeutics, Inc. Filed Acc 0001209191-22-026888
General Counsel sold 660 shares at $11.75 ($7,755)
- General Counsel acquired 1,924 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Ring Christine · General Counsel
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-30 | Exercise or conversion : show line 1 in the form | +1,924 | 4,063 | D | ||
| 2022-05-02 | Sale : show line 2 in the form | −660 | $11.75 | $7,755 | 3,403 | D |
| Open-market sales · 660 sh · avg $11.75 · $7,755 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-30 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −1,924 | 28,861 | D |
Loading xslF345X03/doc4.xml…